Ivermectin Prices June 2023
Product
|
Category |
Region |
Price |
Ivermectin |
Pharma API |
USA |
140520 USD/MT |
Ivermectin |
Pharma API |
China |
130050 USD/MT |
Ivermectin |
Pharma API |
Germany |
141041 USD/MT |
In the second quarter of 2023, the price of ivermectin in the United States reached 140520 USD/MT in June. Similarly, in China, the ivermectin prices hit 130050 USD/MT in the same month. Germany also saw ivermectin prices reaching 141041 USD/MT during Q2 2023.
Ivermectin Price Trend, Market Analysis, and News
IMARC’s newly published report, titled “Ivermectin Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data,” offers an in-depth analysis of ivermectin pricing, covering an analysis of global and regional market trends and the critical factors driving these price movements.
It encompasses an in-depth review of spot price of ivermectin at major ports, a breakdown of prices including Ex Works, FOB, and CIF, alongside a region-wise dissection of ivermectin price trend across North America, Europe, Asia Pacific, Latin America, the Middle East and Africa.
The report examines the elements influencing ivermectin price fluctuations, such as changes in raw material costs, supply-demand dynamics, geopolitical factors, and industry-specific developments. Additionally, it integrates the latest market news, providing stakeholders with up-to-date information on market shifts, regulatory changes, and technological advancements, thereby offering a comprehensive overview that aids in strategic decision-making and forecasting.
Ivermectin Market Analysis
The global ivermectin market size reached US$ 309.2 Million in 2023. By 2032, IMARC Group expects the market to reach US$ 488 Million, at a projected CAGR of 5.20% during 2023-2032.
- The widespread occurrence of parasitic diseases including lymphatic filariasis, onchocerciasis, strongyloidiasis, and scabies particularly in subtropical and tropical regions, is driving the demand for ivermectin as an effective treatment option. According to the World Health Organization (WHO), onchocerciasis, commonly known as “river blindness”, is caused by the parasitic worm Onchocerca volvulus with more than 99% of infected people living in 31 African countries. The disease also exists in some foci in two countries in Latin America (the Yanomanu area in Brazil and Venezuela). The Global Burden of Disease Study estimated in 2017 that at least 220 million people required preventive chemotherapy against onchocerciasis, 14.6 million of the infected people already had skin disease and 1.15 million had vision loss.
- The extensive use of ivermectin in veterinary medicine to control parasitic infections in livestock, pets, and horses significantly contributes to the growth of the market. The livestock industry’s focus on maintaining animal health and productivity further boosts the demand. For instance, in April 2024, Boehringer Ingelheim, a global leader in animal health, announced the launch of NexGard SPECTRA (afoxolaner and milbemycin oxime) in India, following its approval by the Central Drugs Standard Control Organization (CDSCO). NexGard SPECTRA is it soft, flavorful chew for dogs that offers broad-spectrum internal and external parasite control in a single monthly dose. As a prescription-only product in India NexGard SPECTRA contains two active ingredients: afoxolaner, which targets fleas and ticks, and milbemycin oxime, which protects against heartworm and controls intestinal worms. NextGard Spectra provides comprehensive protection in a single monthly chewable, offering convenience, safety, and peace of mind.
- The increasing demand for ivermectin in aquaculture and bee health management to control parasitic infestation supports market growth. Effective parasite control in these sectors is vital for maintaining healthy yields and productivity. According to the data from the Euro Stats, aquaculture farming in the EU yielded almost 1.1 million tonnes of aquatic organisms in 2022, worth EUR 4.8 billion.
Ivermectin News
The report covers the latest developments, updates, and trends impacting the global ivermectin market, providing stakeholders with timely and relevant information. This segment covers a wide array of news items, including the inauguration of new production facilities, advancements in ivermectin production technologies, strategic market expansions by key industry players, and significant mergers and acquisitions that impact the ivermectin price trend.
Latest developments in the ivermectin industry:
- In October 2023, Boehringer Ingelheim and ZEISS Medical Technology announced a long-term strategic collaboration to develop predictive analytics to enable the early detection of eye diseases and prevent vision loss for people with serious eye diseases. The partnership brings together their leading expertise in ophthalmology technology, data analytics, algorithms, and the development of treatments to detect early and treat retinal diseases before irreversible loss of vision occurs.
- In November 22023, Virbac, a global leader in animal health announced the acquisition of Globion, a prominent Indian poultry vaccine specialist. This strategic move reinforces Virbac’s position as a market leader in animal health in India and expands its poultry portfolio to include avian vaccines.
Product Description
Ivermectin refers to a broad-spectrum anti-parasitic agent derived from the avermectin family of compounds. It is extensively in veterinary and human medicines to treat different parasitic infections.
In veterinary medicine, it is widely utilized to control parasites in pets, horses, and livestock I'm not targeting gastrointestinal worms, lice, mites, and lungworms. Ivermectin is also employed in beekeeping and aquaculture to manage parasitic infestations.
In humans, it is majorly used to combat diseases like lymphatic filariasis, onchocerciasis (river blindness), scabies, and strongyloidiasis. It works by binding to and disrupting the nervous system of parasites, leading to their paralysis and death.
It also gained attention during the outbreak of the COVID-19 pandemic for its potential antiviral properties.
The versatility, safety profile, and efficacy of ivermectin make it a vital tool in managing parasitic diseases across different sectors.
Regional Coverage
The report provides a detailed analysis of the ivermectin market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of ex-works, FOB, and CIF prices, as well as the key factors influencing the ivermectin price trend.
Global Ivermectin Price
The report offers a holistic view of the global ivermectin pricing trends in the form of ivermectin price charts, reflecting the worldwide interplay of supply-demand balances, international trade policies, and overarching economic factors that shape the market on a macro level. This comprehensive analysis not only highlights current price of ivermectin but also provides insights into historical price trends, enabling stakeholders to understand past fluctuations and their underlying causes.
The report also delves into price forecast models, projecting future price movements based on a variety of indicators such as expected changes in supply chain dynamics, anticipated policy shifts, and emerging market trends. By examining these factors, the report equips industry participants with the necessary tools to make informed strategic decisions, manage risks, and capitalize on market opportunities. Furthermore, it includes a detailed ivermectin demand analysis, breaking down regional variations and identifying key drivers specific to each geographic market, thus offering a nuanced understanding of the global pricing landscape.
Europe Ivermectin Price
European ivermectin prices are examined, highlighting the market-specific influences in the region, such as stringent environmental regulations, the competitive landscape, and import-export imbalances that significantly affect pricing structures.
This analysis can be extended to include detailed ivermectin price information for a comprehensive list of countries.
Region |
Countries Covered |
Europe |
Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal, and Greece, among other European countries. |
North America Ivermectin Price
The analysis of ivermectin prices in North America delves into the regional industry dynamics, encompassing the impact of local production capacities and the trade flows between North America and other significant global markets.
Specific ivermectin historical data within the United States and Canada can also be provided.
Region |
Countries Covered |
North America |
United States and Canada |
Middle East and Africa Ivermectin Price
The report explores the ivermectin pricing trends in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.
In addition to region-wise data, information on ivermectin prices for countries can also be provided.
Region |
Countries Covered |
Middle East & Africa |
Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco, among other Middle Eastern and African countries. |
Asia Pacific Ivermectin Price
The ivermectin pricing trends in Asia Pacific are examined, reflecting the role of the region as a major global production hub and consumer market, with price dynamics heavily influenced by supply chain efficiencies, regional demand surges, and policy shifts in major economies.
This ivermectin price analysis can be expanded to include a comprehensive list of countries within the region.
Region |
Countries Covered |
Asia Pacific |
China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand, among other Asian countries. |
Latin America Ivermectin Price
The analysis of ivermectin prices in Latin America provides a detailed overview, reflecting the unique market dynamics in the region influenced by economic policies, industrial growth, and trade frameworks.
This comprehensive review can be extended to include specific countries within the region.
Region |
Countries Covered |
Latin America |
Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru, among other Latin American countries. |
Report Coverage
Key Attributes |
Details |
Product Name |
Ivermectin |
Report Features |
Exploration of Historical Trends and Market Outlook, Industry Demand, Industry Supply, Gap Analysis, Challenges, Ivermectin Price Analysis, and Segment-Wise Assessment. |
Currency/Units |
US$ (Data can also be provided in local currency) or Metric Tons |
Region/Countries Covered |
The current coverage includes analysis at the global and regional levels only.
Based on your requirements, we can also customize the report and provide specific information for the following countries:
Asia Pacific: China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand*
Europe: Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal and Greece*
North America: United States and Canada
Latin America: Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru*
Middle East & Africa: Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco*
*The list of countries presented is not exhaustive. Information on additional countries can be provided if required by the client. |
Information Covered for Key Suppliers |
- Company Overview
- Business Description
- Product Portfolio
- Recent Trends and Developments
|
Customization Scope |
The report can be customized as per the requirements of the customer |
Report Price and Purchase Option |
Plan A: Monthly Updates - Annual Subscription
- Scope
- Historical Data for the Current Month
- Forecast for Next Month
- Total Deliverables Per Year: 12 (One Per Month)
- Includes: One PDF and Excel datasheet per month, Post Purchase Analyst Support throughout the year
Plan B: Quarterly Updates - Annual Subscription
- Scope
- Historical Data for the Current Quarter
- Forecast for Next Quarter
- Total Deliverables Per Year: 4 (One Per Quarter)
- Includes: One PDF and Excel datasheet per Quarter, Post Purchase Analyst Support throughout the year
Plan C: Biannually Updates - Annual Subscription
- Scope
- Historical Data for the Current Half
- Forecast for the Next Half
- Total Deliverables Per Year: 2 (One Per 6 Months)
- Includes: One PDF and Excel datasheet per Half, Post Purchase Analyst Support throughout the year
|
Post-Sale Analyst Support |
360-degree analyst support after report delivery |
Delivery Format |
PDF and Excel through email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Benefits for Stakeholders:
- IMARC’s report presents a detailed analysis of ivermectin pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
- The study examines factors affecting ivermectin price trend, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
- The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
- IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights. The ivermectin price charts ensure our clients remain at the forefront of the industry.